合計: 4 |
|
PMID (PMCID) | ||
---|---|---|
20070998 |
MALE | |
Orbital involvement in Castleman disease. | ||
Venizelos I, Papathomas TG, Papathanasiou M, Cheva A, Garypidou V, Coupland S. Surv Ophthalmol. 2010;55(3):247-55. |
||
We report on the first biopsy-proven case of multicentric plasma cell type of Castleman disease involving the orbital areas in a human herpes virus 8 (HHV-8)-unassociated/ human immunodeficiency virus (HIV)-seronegative 70-year-old man suffering from Parkinson disease. | ||
16044438 |
MALE | Adult |
Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease. | ||
Neuville S, Agbalika F, Rabian C, Briere J, Molina JM. Am J Hematol. 2005;79(4):337-9. |
||
Two human immunodeficiency virus-infected patients who needed etoposide therapy to control exacerbations of Castleman disease received four infusions of rituximab. | ||
14987152 |
MALE | Adult |
False-positive D-dimer result in a patient with Castleman disease. | ||
Mugler K, Lefkowitz JB. Arch Pathol Lab Med. 2004;128(3):328-31. |
||
We report the case of a patient with human immunodeficiency virus (HIV) and Castleman disease who presented with a high-positive D-dimer level and a negative FDP level in the course of a workup for disseminated intravascular coagulation. | ||
12715327 |
MALE | Adult |
Epstein-Barr virus and human herpesvirus 8 coinfection and concomitant extranodal nasal-type NK/T cell lymphoma and Castleman disease: case report. | ||
Larroche C, Agbalika F, Poirel H, Martin A, Gautheret-Dejean A, Raphael M, Lortholary O. Clin Infect Dis. 2003;36(9):e107-10. |
||
We describe a 36-year-old man uninfected with human immunodeficiency virus who had confirmed concurrent infection with Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8) and their respective lymphoproliferative manifestations, nasal-type NK/T cell lymphoma and Castleman disease. |